相关实验视频

Updated: Jun 11, 2025

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

在患有高级人类免疫缺陷病毒疾病的患者中,Mpox复发和Tecovirimat耐药性

David C Griffith^1,2, Amary Fall³, Mihaela Carter⁴

¹Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Open forum infectious diseases

|October 7, 2024

概括

莫波克斯复发发生在一个患有艾滋病的跨性别女性身上,表现出tecovirimat抗性突变. 尽管存在治疗挑战,但观察到T细胞对正病毒的强烈反应.

科学领域:

传染性疾病传染性疾病
免疫学免疫学免疫学
病毒学病毒学

背景情况:

麻疹 (Mombox) 是一种由病毒引起的病毒性疾病.
复发的mopox感染和抗病毒耐药性是新出现的担忧.
人类免疫缺陷病毒 (HIV) 感染可能会影响MOPOX疾病的严重程度和免疫反应.

研究的目的:

报告一个患有获得性免疫缺陷综合征 (艾滋病) 的跨性别女性中复发性mopox病例.
为了研究复发性mopox.virus中的抗病毒耐药性.
为了表征复发性mpox期间的免疫反应.

主要方法:

病例报告详细介绍了临床表现,治疗和结果.
猿病毒的基因组测序以确定耐药性突变.
评估T细胞对orthopoxvirus特异性的反应.

主要成果:

复发的mopox病变需要长期抗病毒治疗超过五个月.
在病毒病毒基因组中识别tecovirimat耐药性突变.
证明了强大的骨质疏松病毒特异性T细胞反应,尽管再次感染和耐药性.

结论:

这一案例凸显了复发性MPOX的可能性和抗病毒耐药性的发展,特别是在免疫受损的个体中.
强烈的T细胞反应的存在表明细胞免疫在管理mopox的过程中可能发挥作用,即使有病毒耐药性.
需要进一步的研究来了解mopox的复发,耐药性机制和最佳的治疗策略,特别是在HIV同时感染的背景下.

关键词:

艾滋病病毒艾滋病病毒艾滋病病毒在T细胞,T细胞.一个MPOX的MPOX.电阻的阻力可以德科维里马特 (tecovirimat) 是一个

更多相关视频

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...